Latest On AVEO Pharmaceuticals, Inc (AVEO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-01-06 09:29 EST | News | Aveo Oncology shareholders approve acquisition by LG Chem | N/A |  |
| 2022-11-08 08:38 EST | News | AVEO Pharmaceuticals GAAP EPS of -$0.09 beats by $0.08, revenue of $30.4M beats by $0.54M | N/A | |
| 2022-10-24 19:07 EST | News | AVEO Oncology: The Latest Acquisition Signals More Deals | N/A | |
| 2022-10-18 16:06 EST | News | AVEO Oncology shares jumped on acquisition by LG Chem for $15.00 per share in cash | N/A | |
| 2022-08-16 04:47 EST | News | A Current Assessment On AVEO Pharmaceuticals | N/A | |
| 2022-08-04 23:48 EST | News | AVEO Pharmaceuticals GAAP EPS of -$0.24 beats by $0.04, revenue of $25.3M misses by $0.17M | N/A | |
| 2022-08-04 23:48 EST | News | AVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 17:46 EST | News | AVEO Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-06-22 16:02 EST | News | AVEO Oncology partners with Eli Lilly to develop and supply head and neck cancer combo therapy | N/A | |
| 2022-05-24 14:40 EST | News | AVEO Pharmaceuticals Is Primed For A Breakout | N/A | |
| 2022-05-05 22:42 EST | News | AVEO Pharmaceuticals GAAP EPS of -$0.30, revenue of $20.9M | N/A | |
| 2022-05-05 22:39 EST | News | AVEO Pharmaceuticals' (AVEO) CEO Michael Bailey on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 23:52 EST | News | AVEO Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-03-15 00:14 EST | News | AVEO Pharmaceuticals Inc's (AVEO) CEO Michael Bailey on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-14 07:27 EST | News | AVEO Pharmaceuticals GAAP EPS of -$0.21 beats by $0.07, revenue of $17.65M misses by $0.7M | N/A | |
| 2022-03-09 03:40 EST | News | AVEO Pharmaceuticals: Finally Ready To Reboot | N/A | |
| 2022-01-05 17:47 EST | News | AVEO Oncology slips 10% despite deal to evaluate Fotivda in combination for kidney cancer | N/A | |
| 2021-12-01 18:08 EST | News | AVEO Oncology names Jeb Ledell as COO | N/A | |
| 2021-11-09 04:21 EST | News | AVEO Pharmaceuticals EPS beats by $0.06, beats on revenue | N/A | |
| 2021-11-09 04:20 EST | News | Aveo plans to begin manufacturing clinical supply of biologic for head and neck cancer | N/A | |
| 2021-11-09 04:20 EST | News | AVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q3 2021 Results - Earning Call Transcript | N/A | |
| 2021-11-08 08:02 EST | News | AVEO Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-10-29 14:32 EST | News | AVEO Pharmaceuticals: Sticking To The Plan | N/A | |
| 2021-09-21 12:44 EST | News | AVEO Oncology granted FDA’s Fast Track Designation for cancer therapy | N/A | |
| 2021-08-05 22:40 EST | News | AVEO Pharmaceuticals EPS beats by $0.10, beats on revenue | N/A | |
| 2021-08-05 22:40 EST | News | AVEO Pharmaceuticals, Inc. (AVEO) CEO Michael Bailey on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-24 08:24 EST | News | AVEO Pharmaceuticals: Making Its Mark In Cancer Treatment | N/A | |
| 2021-07-20 20:54 EST | News | AVEO Oncology: Time To Be Patient | N/A | |
| 2021-03-30 02:30 EST | News | AVEO's FOTIVDA added to NCNN clinical practice guidelines | N/A | |
| 2021-03-27 00:07 EST | News | AVEO Oncology ends stock offering, grosses $55M | N/A | |
| 2021-03-24 14:45 EST | News | AVEO raises $48M capital via equity offering | N/A | |
| 2021-03-22 23:11 EST | News | AVEO says FOTIVDA now commercially available in U.S. | N/A | |
| 2021-03-22 23:10 EST | News | AVEO under pressure on launching 5M stock offering | N/A | |
| 2021-03-18 08:12 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-17 19:10 EST | News | AVEO: Drug Approved, But Still A Long Way To Go Before Self Sufficiency | N/A | |
| 2021-03-17 12:08 EST | Earnings Estimate | An EPS average of -$0.50 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-17 12:08 EST | Earnings Estimate | An EPS average of $0.03 is estimated for the 2022 year. | Buy | |
| 2021-03-16 20:07 EST | News | AVEO Oncology to regain ex-North American rights to oncology drug, AV-203 | N/A | |
| 2021-03-16 20:03 EST | News | AVEO Pharmaceuticals EPS misses by $0.06, misses on revenue | N/A | |
| 2021-03-12 20:58 EST | News | AVEO Oncology shares surge on Fotvida deal with BMY in kidney cancer | N/A | |
| 2021-03-12 11:09 EST | Analyst Rating | The Analyst Target Price has increased from $12 to $22.75. | Buy | |
| 2021-03-11 23:59 EST | News | AVEO Oncology announces $20M tranche under Hercules debt facility | N/A | |
| 2021-03-11 03:24 EST | News | AVEO surges on reports of FDA approval for Fotivda (update) | N/A | |
| 2021-01-20 14:42 EST | News | AVEO Oncology announces commitment for $10M loan from Hercules | N/A | |
| 2021-01-20 07:10 EST | Analyst Rating | The Analyst Target Price has increased from $11.25 to $12. | Buy | |
| 2021-01-15 22:19 EST | News | Aveo's tivozanib combo demonstrates 29% partial response in liver cancer study | N/A | |
| 2021-01-07 23:22 EST | News | AVEO outlines 2021 outlook; initiates Phase 1 trial for cancer complication | N/A | |
| 2021-01-02 15:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-27 12:13 EST | News | AVEO Oncology: Managing A Position Ahead Of Tivozanib's PDUFA | N/A | |
| 2020-12-13 03:16 EST | Financials | Company financials have been released. | Neutral | |
About AVEO Pharmaceuticals, Inc (AVEO):
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical needs. It markets its lead candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC). The company has also completed a Phase III TIVO-3 trial of tivozanib for the treatment of RCC; and initiated enrollment in a phase Ib/II clinical trial of tivozanib in combination with Opdivo (nivolumab), an immune checkpoint (PD-1) inhibitor for the treatment of RCC. In addition, it is developing Ficlatuzumab, a potent hepatocyte growth factor inhibitory antibody that is in a Phase II clinical trial for the treatment of squamous cell carcinoma of the head and neck, acute myeloid leukemia, and pancreatic cancer; and AV-203, a potent anti-ErbB3 specific monoclonal antibody, which has completed Phase I clinical trial for treating esophageal cancer. The company's preclinical stage products include AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; and AV-353 for the treatment of pulmonary arterial hypertension. AVEO Pharmaceuticals, Inc. has collaboration agreements with CANbridge Life Sciences Ltd.; EUSA Pharma (UK) Limited; Novartis International Pharmaceutical Ltd.; Biodesix, Inc.; St. Vincent's Hospital Sydney Limited; Biogen Idec International GmbH; and Kyowa Kirin Co., Ltd.; AstraZeneca PLC; and Bristol Myers Squibb. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.
General
- Name AVEO Pharmaceuticals, Inc
- Symbol AVEO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Last Split Factor1:10
- Last Split Date2020-02-20
- Fiscal Year EndDecember
- IPO Date2010-03-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.aveooncology.com
View More
Valuation
- Trailing PE 84.8
- Price/Sales (Trailing 12 Mt.) 39.54
- Price/Book (Most Recent Quarter) 8.55
- Enterprise Value Revenue 42.27
- Enterprise Value EBITDA 48.85
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.04
- Next Year EPS Estimate -$0.17
- Next Quarter EPS Estimate -$0.54
- Operating Margin -646%
- Return on Assets -41%
- Return on Equity -142%
- Revenue 6.02 million
- Earnings Per Share $0.03
- Revenue Per Share $0.28
- Gross Profit -16660000
- Quarterly Earnings Growth 16%
View More
Highlights
- Market Capitalization 276.18 million
- Analyst Target Price $22.75
- Book Value Per Share $1.31
View More
Share Statistics
- Shares Outstanding 27.13 million
- Shares Float 23.33 million
- % Held by Insiders 14%
- % Held by Institutions 34.07%
- Shares Short 1.16 million
- Shares Short Prior Month 911893
- Short Ratio 2.74
- Short % of Float 4%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 1.24
- 52 Week High $13.21
- 52 Week Low $2.4
- 50 Day Moving Average 9.11
- 200 Day Moving Average 6.8
View More
Dividends
- Dividend Date 2020-02-20
- ExDividend Date N/A
- Dividend Yield 0%
View More
AVEO Pharmaceuticals, Inc (AVEO) Dividend Calendar:
AVEO's last dividend payment was made to shareholders on February 20, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
AVEO Pharmaceuticals, Inc (AVEO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $886000 | -$0.44 | -$0.38 | -15.79% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.33 | -$0.23 | -45.05% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.42 | -$0.61 | 30.58% |
| 2020-03-31 | 2020-04-30 | $N/A | -$0.52 | -$0.50 | -4.69% |
| 2019-12-31 | 2020-03-16 | $764000 | -$0.28 | -$0.58 | 51.45% |
| 2019-09-30 | 2019-11-12 | $25.72 million | $1.00 | $0.30 | 233.33% |
| 2019-06-30 | 2019-08-08 | $703000 | -$0.20 | -$0.65 | 69.23% |
| 2019-03-31 | 2019-05-09 | $1.61 million | $0.04 | -$0.55 | 107.64% |
| 2018-12-31 | 2019-03-14 | $1.48 million | $1.80 | -$0.55 | 427.27% |
| 2018-09-30 | 2018-11-09 | $2.47 million | -$1.80 | -$0.63 | -184.23% |
| 2018-06-30 | 2018-08-07 | $433000 | $0.30 | -$0.63 | 147.37% |
| 2018-03-31 | 2018-05-08 | $1.03 million | -$0.80 | -$0.70 | -14.29% |
| 2017-12-31 | 2018-03-13 | $82000 | $0.27 | -$0.30 | 189.67% |
| 2017-09-30 | 2017-11-07 | $4.61 million | -$2.20 | -$0.50 | -340% |
| 2017-06-30 | 2017-08-09 | $351000 | -$3.00 | -$0.90 | -233.33% |
| 2017-03-31 | 2017-05-04 | $2.53 million | -$1.20 | -$1.20 | 0% |
| 2016-12-31 | 2017-03-22 | $127000 | -$0.70 | -$1.20 | 41.67% |
| 2016-09-30 | 2016-11-04 | $992000 | -$0.70 | -$1.15 | 39.13% |
| 2016-06-30 | 2016-08-04 | $193000 | -$1.14 | -$1.40 | 18.79% |
| 2016-03-31 | 2016-05-10 | $1.2 million | -$1.30 | -$1.30 | 0% |
| 2015-12-31 | 2016-03-15 | $3.6 million | -$0.11 | -$0.04 | -175% |
| 2015-09-30 | 2015-11-09 | $15.16 million | $0.14 | -$0.09 | 255.56% |
| 2015-06-30 | 2015-08-10 | $134000 | -$0.10 | -$0.20 | 50% |
| 2015-03-31 | 2015-05-07 | $134000 | -$0.21 | -$0.24 | 12.5% |
| 2014-12-31 | 2015-03-06 | $116000 | -$0.27 | -$0.21 | -28.57% |
| 2014-09-30 | 2014-11-05 | $872000 | -$0.28 | -$0.23 | -21.74% |
| 2014-06-30 | 2014-08-11 | $1.85 million | -$0.35 | -$0.44 | 20.45% |
| 2014-03-31 | 2014-05-07 | $15.29 million | -$1.20 | -$4.02 | 70.15% |
| 2013-12-31 | 2014-03-13 | $323000 | -$3.20 | -$3.25 | 1.54% |
| 2013-09-30 | 2013-11-07 | $323000 | -$4.70 | -$4.71 | 0.21% |
| 2013-06-30 | 2013-08-08 | $324000 | -$4.70 | -$5.61 | 16.22% |
| 2013-03-31 | 2013-04-29 | $323000 | -$6.90 | -$7.19 | 4.03% |
| 2012-12-31 | 2013-02-13 | $15.53 million | -$4.30 | -$7.69 | 44.08% |
| 2012-09-30 | 2012-10-30 | $1.02 million | -$6.90 | -$8.66 | 20.32% |
| 2012-06-30 | 2012-08-02 | $1.88 million | -$6.80 | -$8.91 | 23.68% |
| 2012-03-31 | 2012-05-03 | $860000 | -$7.70 | -$7.61 | -1.18% |
| 2011-12-31 | 2012-02-14 | $1.1 million | -$5.80 | -$6.12 | 5.23% |
| 2011-09-30 | 2011-11-02 | $3.59 million | -$5.50 | -$5.50 | 0% |
| 2011-06-30 | 2011-07-28 | $26.55 million | -$1.60 | -$7.52 | 78.72% |
| 2011-03-31 | 2011-04-28 | $133.61 million | $22.80 | -$5.67 | 502.12% |
| 2010-12-31 | 2011-02-16 | $11.96 million | -$3.00 | -$6.42 | 53.27% |
| 2010-09-30 | 2010-11-04 | $6.22 million | -$6.00 | -$6.17 | 2.76% |
| 2010-06-30 | 2010-07-29 | $15.62 million | -$5.00 | -$3.50 | -42.86% |
| 2010-03-31 | 2010-04-29 | $10.88 million | -$6.90 | -$7.00 | 1.43% |
AVEO Pharmaceuticals, Inc (AVEO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 4.57 million | N/A | N/A | N/A | 17.96 million |
| Income Before Tax | -11.5 million | N/A | N/A | N/A | -4.46 million |
| Selling General Administrative | 9.01 million | N/A | N/A | N/A | 2.89 million |
| Gross Profit | N/A | N/A | N/A | N/A | 14.21 million |
| Ebit | -10.97 million | N/A | N/A | N/A | -6.63 million |
| Operating Income | -12.7 million | N/A | N/A | N/A | -6.63 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 886000 | N/A | N/A | N/A | 764000 |
| Cost of Revenue | N/A | N/A | N/A | N/A | -13.45 million |
| Total Other Income Expense Net | 1.71 million | N/A | N/A | N/A | 2.17 million |
| Net Income From Continuing Operations | -11.5 million | N/A | N/A | N/A | -4.46 million |
| Net Income Applicable to Common Shares | -11.5 million | -8.39 million | -7.31 million | -8.38 million | -4.46 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | -17.92 million | N/A |
| Change to Liabilities | -279000 | -1.67 million | 1.01 million | -1.21 million | -274000 |
| Total Cash Flow from Investing Activities | -3.31 million | -15.59 million | 7.75 million | -17.92 million | N/A |
| Net Borrowings | 3.67 million | -2.44 million | -2.39 million | -2.33 million | -1.51 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | -2.58 million | -1.5 million |
| Change to Operating Activities | 1.64 million | -313000 | -1.12 million | 764000 | 470000 |
| Change in Cash | N/A | N/A | N/A | -27.87 million | 17.42 million |
| Total Cash from Operating Activities | -5.89 million | -7.53 million | -11.69 million | -7.37 million | 18.92 million |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | -541000 | -479000 |
| Other Cash Flow from Financing Activities | -255000 | N/A | N/A | -300000 | N/A |
| Change to Net Income | 983000 | 189000 | -2.05 million | -1.92 million | 2.77 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 31.62 million | N/A | N/A | N/A | 35.75 million |
| Total Stockholder Equity | 35.29 million | N/A | N/A | N/A | 14.85 million |
| Other Current Liabilities | 2.96 million | 4.68 million | N/A | N/A | 1.97 million |
| Total Assets | 66.91 million | N/A | N/A | N/A | 50.6 million |
| Common Stock | 27000 | 26000 | 26000 | 161000 | 161000 |
| Other Current Assets | 355000 | 476000 | N/A | N/A | 589000 |
| Retained Earnings | -621.21 million | -609.7 million | -601.31 million | -594 million | -585.62 million |
| Other Liabilities | 1.62 million | 2.12 million | 4.35 million | 5.3 million | 8.44 million |
| Other Assets | 158000 | 158000 | 158000 | 158000 | N/A |
| Cash | 61.76 million | N/A | N/A | N/A | 29.79 million |
| Total Current Liabilities | 16.95 million | 16.69 million | N/A | N/A | 21.12 million |
| Other Stockholder Equity | N/A | 1000 | -1000 | N/A | N/A |
| Property, Plant & Equipment | 1.25 million | 1.22 million | 1.22 million | 1.33 million | N/A |
| Total Current Assets | 65.51 million | 71.64 million | N/A | N/A | 50.6 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 35.29 million | 40.22 million | 48.05 million | 7.01 million | 14.85 million |
| Short Term Investments | N/A | N/A | N/A | N/A | 17.96 million |
| Long Term Debt | 12.72 million | N/A | N/A | N/A | 6.2 million |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 3.38 million | 2 million | N/A | N/A | 1.47 million |
AVEO Pharmaceuticals, Inc (AVEO) Chart:
AVEO Pharmaceuticals, Inc (AVEO) News:
Below you will find a list of latest news for AVEO Pharmaceuticals, Inc (AVEO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
AVEO Pharmaceuticals, Inc (AVEO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest AVEO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:58 PM EST | 162 | $3.99 |
| Jun 13, 2022 7:58 PM EST | 238 | $3.99 |
| Jun 13, 2022 7:58 PM EST | 262 | $3.99 |
| Jun 13, 2022 7:58 PM EST | 200 | $4.005 |
| Jun 13, 2022 7:59 PM EST | 11 | $4.015 |
AVEO Pharmaceuticals, Inc (AVEO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017979/0000899243-20-017979-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000021545719006669/0000215457-19-006669-index.htm |
| 2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000021545719007856/0000215457-19-007856-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319003033/0000899243-19-003033-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319003035/0000899243-19-003035-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319003036/0000899243-19-003036-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319003037/0000899243-19-003037-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319003040/0000899243-19-003040-index.htm |
| 2019-03-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319005474/0000899243-19-005474-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319005477/0000899243-19-005477-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319016834/0000899243-19-016834-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319016835/0000899243-19-016835-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319016837/0000899243-19-016837-index.htm |
| 2019-06-14 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319016960/0000899243-19-016960-index.htm |
| 2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319027690/0000899243-19-027690-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319027691/0000899243-19-027691-index.htm |
| 2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924319028068/0000899243-19-028068-index.htm |
| 2020-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320000826/0000899243-20-000826-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320000827/0000899243-20-000827-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320003699/0000899243-20-003699-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320003700/0000899243-20-003700-index.htm |
| 2020-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320003702/0000899243-20-003702-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017965/0000899243-20-017965-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017969/0000899243-20-017969-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017970/0000899243-20-017970-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017971/0000899243-20-017971-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000089924320017979/0000899243-20-017979-index.htm |
| 2020-06-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000092963820000691/0000929638-20-000691-index.htm |
| 2020-06-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000092963820000692/0000929638-20-000692-index.htm |
| 2019-04-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1325879/000107261319000186/0001072613-19-000186-index.htm |
| 2020-06-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1325879/000107261320000211/0001072613-20-000211-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000117266119000626/0001172661-19-000626-index.htm |
| 2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312518352566/0001193125-18-352566-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519029719/0001193125-19-029719-index.htm |
| 2019-02-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519042489/0001193125-19-042489-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519061139/0001193125-19-061139-index.htm |
| 2019-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519082222/0001193125-19-082222-index.htm |
| 2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519096024/0001193125-19-096024-index.htm |
| 2019-04-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1325879/000119312519096640/0001193125-19-096640-index.htm |
| 2019-04-04 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1325879/000119312519097940/0001193125-19-097940-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519097946/0001193125-19-097946-index.htm |
| 2019-05-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000119312519162987/0001193125-19-162987-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519172470/0001193125-19-172470-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519209603/0001193125-19-209603-index.htm |
| 2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519230981/0001193125-19-230981-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519241618/0001193125-19-241618-index.htm |
| 2019-09-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519243888/0001193125-19-243888-index.htm |
| 2019-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519247006/0001193125-19-247006-index.htm |
| 2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519256524/0001193125-19-256524-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519261229/0001193125-19-261229-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519284004/0001193125-19-284004-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312519295580/0001193125-19-295580-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520002244/0001193125-20-002244-index.htm |
| 2020-01-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000119312520013554/0001193125-20-013554-index.htm |
| 2020-02-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000119312520023464/0001193125-20-023464-index.htm |
| 2020-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520035652/0001193125-20-035652-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520042086/0001193125-20-042086-index.htm |
| 2020-05-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000119312520153084/0001193125-20-153084-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520153095/0001193125-20-153095-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520155052/0001193125-20-155052-index.htm |
| 2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520157210/0001193125-20-157210-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520165801/0001193125-20-165801-index.htm |
| 2020-06-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1325879/000119312520169509/0001193125-20-169509-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520169515/0001193125-20-169515-index.htm |
| 2020-06-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1325879/000119312520171444/0001193125-20-171444-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520171457/0001193125-20-171457-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520187888/0001193125-20-187888-index.htm |
| 2020-09-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000119312520240516/0001193125-20-240516-index.htm |
| 2020-06-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1325879/000119380520000719/0001193805-20-000719-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062247/0001209191-18-062247-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062248/0001209191-18-062248-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062249/0001209191-18-062249-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062251/0001209191-18-062251-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062252/0001209191-18-062252-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062255/0001209191-18-062255-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062256/0001209191-18-062256-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062257/0001209191-18-062257-index.htm |
| 2018-12-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062258/0001209191-18-062258-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023995/0001209191-19-023995-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023996/0001209191-19-023996-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023997/0001209191-19-023997-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023998/0001209191-19-023998-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023999/0001209191-19-023999-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024000/0001209191-19-024000-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024002/0001209191-19-024002-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024004/0001209191-19-024004-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024005/0001209191-19-024005-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038234/0001209191-20-038234-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038235/0001209191-20-038235-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038238/0001209191-20-038238-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038240/0001209191-20-038240-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038243/0001209191-20-038243-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038244/0001209191-20-038244-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038246/0001209191-20-038246-index.htm |
| 2019-03-14 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1325879/000156459019007804/0001564590-19-007804-index.htm |
| 2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459019007810/0001564590-19-007810-index.htm |
| 2019-04-19 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1325879/000156459019012116/0001564590-19-012116-index.htm |
| 2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1325879/000156459019013948/0001564590-19-013948-index.htm |
| 2019-04-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000156459019013954/0001564590-19-013954-index.htm |
| 2019-04-30 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1325879/000156459019014349/0001564590-19-014349-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459019017563/0001564590-19-017563-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1325879/000156459019017952/0001564590-19-017952-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459019030409/0001564590-19-030409-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1325879/000156459019030755/0001564590-19-030755-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1325879/000156459019042532/0001564590-19-042532-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459019042534/0001564590-19-042534-index.htm |
| 2019-12-16 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1325879/000156459019046077/0001564590-19-046077-index.htm |
| 2020-01-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1325879/000156459020000448/0001564590-20-000448-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1325879/000156459020011145/0001564590-20-011145-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459020011147/0001564590-20-011147-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1325879/000156459020019292/0001564590-20-019292-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1325879/000156459020019299/0001564590-20-019299-index.htm |
| 2020-04-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1325879/000156459020019921/0001564590-20-019921-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459020019949/0001564590-20-019949-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1325879/000156459020038899/0001564590-20-038899-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1325879/000156459020038919/0001564590-20-038919-index.htm |
| 2019-03-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1325879/999999999719001377/9999999997-19-001377-index.htm |
| 2019-05-01 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1325879/999999999719003671/9999999997-19-003671-index.htm |
| 2019-11-29 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1325879/999999999719007724/9999999997-19-007724-index.htm |
| 2020-04-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1325879/999999999720002042/9999999997-20-002042-index.htm |
| 2020-04-23 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1325879/999999999720002043/9999999997-20-002043-index.htm |
AVEO Pharmaceuticals, Inc (AVEO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AVEO Pharmaceuticals, Inc (AVEO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 14%Institutional Ownership: 3407%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-06 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm |
| 2018-12-06 | DAVID M MOTT | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm |
| 2018-12-06 | FOREST BASKETT | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm |
| 2018-12-06 | JOSHUA MAKOWER | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm |
| 2018-12-06 | Mohamad Makhzoumi | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm |
| 2018-12-06 | Peter W. Sonsini | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm |
| 2018-12-06 | SCOTT D SANDELL | 10% Share Holder | Buy | 27,300.00 | 1.99 | 54,414.36 | 20,191,738.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm |
| 2018-12-07 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm |
| 2018-12-07 | DAVID M MOTT | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm |
| 2018-12-07 | FOREST BASKETT | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm |
| 2018-12-07 | JOSHUA MAKOWER | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm |
| 2018-12-07 | Mohamad Makhzoumi | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm |
| 2018-12-07 | Peter W. Sonsini | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm |
| 2018-12-07 | SCOTT D SANDELL | 10% Share Holder | Buy | 117,100.00 | 1.98 | 232,361.53 | 20,308,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm |
| 2018-12-10 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061837/0001209191-18-061837-index.htm |
| 2018-12-10 | DAVID M MOTT | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061840/0001209191-18-061840-index.htm |
| 2018-12-10 | FOREST BASKETT | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061835/0001209191-18-061835-index.htm |
| 2018-12-10 | JOSHUA MAKOWER | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061839/0001209191-18-061839-index.htm |
| 2018-12-10 | Mohamad Makhzoumi | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061838/0001209191-18-061838-index.htm |
| 2018-12-10 | Peter W. Sonsini | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061842/0001209191-18-061842-index.htm |
| 2018-12-10 | SCOTT D SANDELL | 10% Share Holder | Buy | 26,000.00 | 1.98 | 51,576.20 | 20,334,838.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118061841/0001209191-18-061841-index.htm |
| 2018-12-11 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062251/0001209191-18-062251-index.htm |
| 2018-12-11 | DAVID M MOTT | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062256/0001209191-18-062256-index.htm |
| 2018-12-11 | FOREST BASKETT | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062249/0001209191-18-062249-index.htm |
| 2018-12-11 | Growth Equity Opportunities IV, LLC | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062247/0001209191-18-062247-index.htm |
| 2018-12-11 | JOSHUA MAKOWER | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062255/0001209191-18-062255-index.htm |
| 2018-12-11 | Mohamad Makhzoumi | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062252/0001209191-18-062252-index.htm |
| 2018-12-11 | PETER J BARRIS | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062248/0001209191-18-062248-index.htm |
| 2018-12-11 | Peter W. Sonsini | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062258/0001209191-18-062258-index.htm |
| 2018-12-11 | SCOTT D SANDELL | 10% Share Holder | Buy | 61,200.00 | 1.98 | 121,084.20 | 20,396,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118062257/0001209191-18-062257-index.htm |
| 2018-12-20 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm |
| 2018-12-20 | DAVID M MOTT | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm |
| 2018-12-20 | FOREST BASKETT | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm |
| 2018-12-20 | Growth Equity Opportunities IV, LLC | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm |
| 2018-12-20 | JOSHUA MAKOWER | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm |
| 2018-12-20 | Mohamad Makhzoumi | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm |
| 2018-12-20 | PETER J BARRIS | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm |
| 2018-12-20 | Peter W. Sonsini | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm |
| 2018-12-20 | SCOTT D SANDELL | 10% Share Holder | Buy | 200,000.00 | 1.63 | 326,060.00 | 20,596,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm |
| 2018-12-21 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064027/0001209191-18-064027-index.htm |
| 2018-12-21 | DAVID M MOTT | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064030/0001209191-18-064030-index.htm |
| 2018-12-21 | FOREST BASKETT | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064026/0001209191-18-064026-index.htm |
| 2018-12-21 | Growth Equity Opportunities IV, LLC | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064024/0001209191-18-064024-index.htm |
| 2018-12-21 | JOSHUA MAKOWER | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064029/0001209191-18-064029-index.htm |
| 2018-12-21 | Mohamad Makhzoumi | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064028/0001209191-18-064028-index.htm |
| 2018-12-21 | PETER J BARRIS | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064025/0001209191-18-064025-index.htm |
| 2018-12-21 | Peter W. Sonsini | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064032/0001209191-18-064032-index.htm |
| 2018-12-21 | SCOTT D SANDELL | 10% Share Holder | Buy | 300,000.00 | 1.49 | 448,380.00 | 20,896,038.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919118064031/0001209191-18-064031-index.htm |
| 2019-04-08 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023998/0001209191-19-023998-index.htm |
| 2019-04-08 | DAVID M MOTT | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024002/0001209191-19-024002-index.htm |
| 2019-04-08 | FOREST BASKETT | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023997/0001209191-19-023997-index.htm |
| 2019-04-08 | Growth Equity Opportunities Fund IV, LLC | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023995/0001209191-19-023995-index.htm |
| 2019-04-08 | JOSHUA MAKOWER | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024000/0001209191-19-024000-index.htm |
| 2019-04-08 | Mohamad Makhzoumi | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023999/0001209191-19-023999-index.htm |
| 2019-04-08 | PETER J BARRIS | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119023996/0001209191-19-023996-index.htm |
| 2019-04-08 | Peter W. Sonsini | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024005/0001209191-19-024005-index.htm |
| 2019-04-08 | SCOTT D SANDELL | 10% Share Holder | Buy | 4,347,827.00 | 1.14 | 4,956,522.78 | 25,243,865.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919119024004/0001209191-19-024004-index.htm |
| 2019-11-21 | MICHAEL P BAILEY | President & CEO | Buy | 150,000.00 | 0.60 | 89,595.00 | 318,848.00 | https://www.sec.gov/Archives/edgar/data/1325879/000089924319028068/0000899243-19-028068-index.htm |
| 2020-06-19 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038238/0001209191-20-038238-index.htm |
| 2020-06-19 | FOREST BASKETT | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038235/0001209191-20-038235-index.htm |
| 2020-06-19 | Growth Equity Opportunities Fund IV, LLC | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038234/0001209191-20-038234-index.htm |
| 2020-06-19 | JOSHUA MAKOWER | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038243/0001209191-20-038243-index.htm |
| 2020-06-19 | Mohamad Makhzoumi | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038240/0001209191-20-038240-index.htm |
| 2020-06-19 | Peter W. Sonsini | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038246/0001209191-20-038246-index.htm |
| 2020-06-19 | SCOTT D SANDELL | 10% Share Holder | Buy | 1,428,571.00 | 5.25 | 7,499,997.75 | 3,952,958.00 | https://www.sec.gov/Archives/edgar/data/1325879/000120919120038244/0001209191-20-038244-index.htm |